{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:40:05Z","timestamp":1761504005467,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.yebeh.2020.107555","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:01:36Z","timestamp":1606168896000},"page":"107555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: A prospective study"],"prefix":"10.1016","volume":"113","author":[{"given":"Kai-li","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Xiu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan-zi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yebeh.2020.107555_b0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/17512433.2015.1091302","article-title":"The effect of antiepileptic drugs on thyroid hormonal function: causes and implications","volume":"8","author":"Hamed","year":"2015","journal-title":"Expert Rev Clin Phar"},{"issue":"8","key":"10.1016\/j.yebeh.2020.107555_b0010","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3390\/ijms17081242","article-title":"The impact of anti-epileptic drugs on growth and bone metabolism","volume":"17","author":"Hueng","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107555_b0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2009.09.008","article-title":"Antiepileptic drugs and hormones in children","volume":"89","author":"Cansu","year":"2010","journal-title":"Epilepsy Res"},{"issue":"12","key":"10.1016\/j.yebeh.2020.107555_b0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00228-005-0056-0","article-title":"Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction","volume":"61","author":"Benedetti","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107555_b0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cbpa.2006.01.033","article-title":"Thyroid hormone and gamma-aminobutynic acid(GABA) interactions in neuroendocrine systems","volume":"144","author":"Wiens","year":"2006","journal-title":"Comp Biochem Physiol A Mol integr Physiol"},{"key":"10.1016\/j.yebeh.2020.107555_b0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2017.03.013","article-title":"The effect of VPA on bone: from clinical studies to cell cultures\u2014The molecular mechanisms revisited","volume":"48","author":"Pitetzis","year":"2017","journal-title":"Seizure"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2020.107555_b0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/epi4.5","article-title":"Classification of the epilepsies: new concepts for discussion and debate\u2014special report of the ILAE Classification Task Force of the Commission for Classification and Terminology","volume":"1","author":"Scheffer","year":"2016","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107555_b0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bcp.13400","article-title":"Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and children","volume":"84","author":"van Dijkman","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107555_b0045","doi-asserted-by":"crossref","unstructured":"Samaniego EA, Sheth RD. Bone consequences of epilepsy and antiepileptic medications [C]\/\/Seminars in pediatric neurology. WB Saunders 2007;14(4):196-200.doi:10.1016\/j.spen. 2007.08.006.","DOI":"10.1016\/j.spen.2007.08.006"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107555_b0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yebeh.2009.02.022","article-title":"Epilepsy and hormones:a critical review","volume":"15","author":"Luef","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"1\u20133","key":"10.1016\/j.yebeh.2020.107555_b0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eplepsyres.2005.08.004","article-title":"Serum thyroid hormone balance and lipid profile in patients with epilepsy","volume":"66","author":"Hamed","year":"2005","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107555_b0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/11594250-000000000-00000","article-title":"Corticosteroid-induced osteoporosis: an update for dermatologists","volume":"13","author":"Clarke","year":"2012","journal-title":"AM J Clin Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2020.107555_b0065","first-page":"31","article-title":"Epilepsy and hormones","volume":"34","author":"Motta","year":"2000","journal-title":"Neurol Neurochir Pol"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107555_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/00207454.2011.627486","article-title":"Thyroid hormones in children on antiepileptic therapy","volume":"122","author":"Ayg\u00fcn","year":"2012","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107555_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.seizure.2013.09.006","article-title":"The effect of antiepileptic drugs on thyroid function in children","volume":"23","author":"Y\u0131lmaz","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107555_b0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yebeh.2018.11.003","article-title":"Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: a prospective observational study","volume":"90","author":"Nishiyama","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107555_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.seizure.2017.03.011","article-title":"Effects of antiepileptic drugs on thyroid hormone function in epileptic patients","volume":"48","author":"Shih","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107555_b0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107555_b0095","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1528-1167.2006.00821.x","article-title":"The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate","volume":"47","author":"Cansu","year":"2006","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107555_b0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ene.12262","article-title":"Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study","volume":"21","author":"Garoufi","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2020.107555_b0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2016.01.010","article-title":"Effects of antiepileptic drug on thyroid hormones in patients with epilepsy: a meta-analysis","volume":"35","author":"Zhang","year":"2016","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107555_b0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yebeh.2009.07.014","article-title":"Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study","volume":"16","author":"Lossius","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2020.107555_b0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0883073812443005","article-title":"Antiepileptic drugs and bone metabolism in children: data from 128 patients","volume":"28","author":"Peter","year":"2013","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2020.107555_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2017.04.824","article-title":"Effect of antiepileptic drugs on bone mineral density in pediatric epilepsy patients","volume":"21","author":"Bin","year":"2017","journal-title":"Eur J Paediatr Neuro"},{"issue":"10","key":"10.1016\/j.yebeh.2020.107555_b0125","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":"Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism","volume":"48","author":"Nissen","year":"2007","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107555_b0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1528-1167.2006.00460.x","article-title":"Vitamin D levels and bone tumover in epilepsy patients taking carbamazepine or oxcarbazepine","volume":"47","author":"Mintzer","year":"2006","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2020.107555_b0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2008.07.001","article-title":"Evaluation of bone turnover in epileptic children using oxcarbazepine","volume":"39","author":"Cansu","year":"2008","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2020.107555_b0140","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.eplepsyres.2013.09.009","article-title":"Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy","volume":"108","author":"Koo","year":"2014","journal-title":"Epilepsy Res"},{"issue":"1","key":"10.1016\/j.yebeh.2020.107555_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-016-0597-7","article-title":"Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children-a medical center experience","volume":"16","author":"Lin","year":"2016","journal-title":"Bmc Pediatr"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020307356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:34:23Z","timestamp":1761503663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020307356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":29,"alternative-id":["S1525505020307356"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107555","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of levetiracetam and oxcarbazepine monotherapy on thyroid hormones and bone metabolism in children with epilepsy: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107555"}}